3.22.1 html 122 213 1 false 39 0 false 6 false false R1.htm 100000 - Document - Cover Page Sheet http://karyopharm.com/20220331/taxonomy/role/CoverPage Cover Page Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets Sheet http://karyopharm.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://karyopharm.com/20220331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100040 - Statement - Condensed Consolidated Statements of Operations Sheet http://karyopharm.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 100050 - Statement - Condensed Consolidated Statements of Comprehensive Loss Sheet http://karyopharm.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLoss Condensed Consolidated Statements of Comprehensive Loss Statements 5 false false R6.htm 100060 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://karyopharm.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 100070 - Statement - Condensed Consolidated Statements of Stockholders' Equity Sheet http://karyopharm.com/20220331/taxonomy/role/StatementCondensedConsolidatedStatementsOfStockholdersEquity Condensed Consolidated Statements of Stockholders' Equity Statements 7 false false R8.htm 100080 - Disclosure - Nature of Business and Basis of Presentation Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureNatureOfBusinessAndBasisOfPresentation Nature of Business and Basis of Presentation Notes 8 false false R9.htm 100100 - Disclosure - Product Revenue Sheet http://karyopharm.com/20220331/taxonomy/role/ProductRevenue Product Revenue Notes 9 false false R10.htm 100110 - Disclosure - Inventory Sheet http://karyopharm.com/20220331/taxonomy/role/Inventory Inventory Notes 10 false false R11.htm 100120 - Disclosure - License and Asset Purchase Agreements Sheet http://karyopharm.com/20220331/taxonomy/role/LicenseAndAssetPurchaseAgreements License and Asset Purchase Agreements Notes 11 false false R12.htm 100140 - Disclosure - Fair Value of Financial Instruments Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureFairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 12 false false R13.htm 100150 - Disclosure - Investments Sheet http://karyopharm.com/20220331/taxonomy/role/Investments Investments Notes 13 false false R14.htm 100160 - Disclosure - Net Loss Per Share Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureNetLossPerShare Net Loss Per Share Notes 14 false false R15.htm 100170 - Disclosure - Stock-based Compensation Expense Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureStockbasedCompensationExpense Stock-based Compensation Expense Notes 15 false false R16.htm 100180 - Disclosure - Stockholders' Equity Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureStockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 100190 - Disclosure - Long-Term Obligations Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureLongtermObligations1 Long-Term Obligations Notes 17 false false R18.htm 100210 - Disclosure - Nature of Business and Basis of Presentation (Policies) Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureNatureOfBusinessAndBasisOfPresentationPolicies Nature of Business and Basis of Presentation (Policies) Policies 18 false false R19.htm 100220 - Disclosure - Product Revenue (Tables) Sheet http://karyopharm.com/20220331/taxonomy/role/ProductRevenueTables Product Revenue (Tables) Tables http://karyopharm.com/20220331/taxonomy/role/ProductRevenue 19 false false R20.htm 100230 - Disclosure - Inventory (Tables) Sheet http://karyopharm.com/20220331/taxonomy/role/InventoryTables Inventory (Tables) Tables http://karyopharm.com/20220331/taxonomy/role/Inventory 20 false false R21.htm 100250 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://karyopharm.com/20220331/taxonomy/role/DisclosureFairValueOfFinancialInstruments 21 false false R22.htm 100260 - Disclosure - Investments (Tables) Sheet http://karyopharm.com/20220331/taxonomy/role/InvestmentsTables Investments (Tables) Tables http://karyopharm.com/20220331/taxonomy/role/Investments 22 false false R23.htm 100270 - Disclosure - Net Loss Per Share (Tables) Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://karyopharm.com/20220331/taxonomy/role/DisclosureNetLossPerShare 23 false false R24.htm 100280 - Disclosure - Stock-based Compensation (Tables) Sheet http://karyopharm.com/20220331/taxonomy/role/StockBasedCompensationTables Stock-based Compensation (Tables) Tables http://karyopharm.com/20220331/taxonomy/role/DisclosureStockbasedCompensationExpense 24 false false R25.htm 100290 - Disclosure - Long-Term Obligations (Tables) Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureLongtermObligationsTables Long-Term Obligations (Tables) Tables http://karyopharm.com/20220331/taxonomy/role/DisclosureLongtermObligations1 25 false false R26.htm 100320 - Disclosure - Product Revenue - Summary of Product Revenue (Details) Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureProductRevenueSummaryOfProductRevenueDetails Product Revenue - Summary of Product Revenue (Details) Details 26 false false R27.htm 100330 - Disclosure - Product Revenue - Additional Information (Detail) Sheet http://karyopharm.com/20220331/taxonomy/role/ProductRevenueAdditionalInformationDetail Product Revenue - Additional Information (Detail) Details 27 false false R28.htm 100340 - Disclosure - Inventory - Schedule of Inventory Current (Detail) Sheet http://karyopharm.com/20220331/taxonomy/role/InventoryScheduleOfInventoryCurrentDetail Inventory - Schedule of Inventory Current (Detail) Details 28 false false R29.htm 100370 - Disclosure - License and Asset Purchase Agreements - Additional Information (Detail) Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureLicenseAndAssetPurchaseAgreementsAdditionalInformationDetail License and Asset Purchase Agreements - Additional Information (Detail) Details 29 false false R30.htm 100390 - Disclosure - Asset Acquisition - Additional Information (Details) Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureAssetAcquisitionAdditionalInformationDetails Asset Acquisition - Additional Information (Details) Details 30 false false R31.htm 100400 - Disclosure - Fair Value of Financial Instruments - Schedule of Financial Assets That Have Been Measured at Fair Value (Details) Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfFinancialAssetsThatHaveBeenMeasuredAtFairValueDetails Fair Value of Financial Instruments - Schedule of Financial Assets That Have Been Measured at Fair Value (Details) Details 31 false false R32.htm 100410 - Disclosure - Investments - Summary of Investments, Classified as Available-for-Sale (Detail) Sheet http://karyopharm.com/20220331/taxonomy/role/InvestmentsSummaryOfInvestmentsClassifiedAsAvailableForSaleDetail Investments - Summary of Investments, Classified as Available-for-Sale (Detail) Details 32 false false R33.htm 100420 - Disclosure - Investments - Additional Information (Detail) Sheet http://karyopharm.com/20220331/taxonomy/role/InvestmentsAdditionalInformationDetail Investments - Additional Information (Detail) Details 33 false false R34.htm 100430 - Disclosure - Investments - Debt Securities Available-For-Sale (Detail) Sheet http://karyopharm.com/20220331/taxonomy/role/InvestmentsDebtSecuritiesAvailableForSaleDetail Investments - Debt Securities Available-For-Sale (Detail) Details 34 false false R35.htm 100440 - Disclosure - Net Loss Per Share (Additional Information) (Details) Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetails Net Loss Per Share (Additional Information) (Details) Details http://karyopharm.com/20220331/taxonomy/role/DisclosureNetLossPerShareTables 35 false false R36.htm 100450 - Disclosure - Net Loss Per Share - Schedule of Potentially Dilutive Securities Were Excluded From The Calculation of Diluted Net Loss Per Share Due to Their Anti-Dilutive Effect (Detail) Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSecuritiesWereExcludedFromTheCalculationOfDilutedNetLossPerShareDueToTheirAntidi Net Loss Per Share - Schedule of Potentially Dilutive Securities Were Excluded From The Calculation of Diluted Net Loss Per Share Due to Their Anti-Dilutive Effect (Detail) Details 36 false false R37.htm 100470 - Disclosure - Stock-based Compensation - Schedule of Total Stock-based Compensation Expense Recognized in Connection with All Share-based Payment Awards (Detail) Sheet http://karyopharm.com/20220331/taxonomy/role/StockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseRecognizedInConnectionWithAllShareBasedPaymentAwardsDetail Stock-based Compensation - Schedule of Total Stock-based Compensation Expense Recognized in Connection with All Share-based Payment Awards (Detail) Details 37 false false R38.htm 100520 - Disclosure - Stockholders' Equity - Open Market Sale Agreement - Additional Information (Detail) Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureStockholdersEquityOpenMarketSaleAgreementAdditionalInformationDetail Stockholders' Equity - Open Market Sale Agreement - Additional Information (Detail) Details 38 false false R39.htm 100530 - Disclosure - Long-Term Obligations - Additional Information (Detail) Sheet http://karyopharm.com/20220331/taxonomy/role/DisclosureLongtermObligationsAdditionalInformationDetail Long-Term Obligations - Additional Information (Detail) Details 39 false false R40.htm 100540 - Disclosure - Long-Term Obligations - Summary of Outstanding Balances of Convertible Notes (Detail) Notes http://karyopharm.com/20220331/taxonomy/role/DisclosureLongtermObligationsSummaryOfOutstandingBalancesOfConvertibleNotesDetail Long-Term Obligations - Summary of Outstanding Balances of Convertible Notes (Detail) Details 40 false false R41.htm 100550 - Disclosure - Long-Term Obligations - Schedule of Interest Expense Recognized Related to Convertible Notes (Detail) Notes http://karyopharm.com/20220331/taxonomy/role/DisclosureLongtermObligationsScheduleOfInterestExpenseRecognizedRelatedToConvertibleNotesDetail Long-Term Obligations - Schedule of Interest Expense Recognized Related to Convertible Notes (Detail) Details 41 false false R42.htm 100560 - Disclosure - Long-Term Obligations - Summary of Future Minimum Payments on Convertible Notes (Detail) Notes http://karyopharm.com/20220331/taxonomy/role/DisclosureLongtermObligationsSummaryOfFutureMinimumPaymentsOnConvertibleNotesDetail Long-Term Obligations - Summary of Future Minimum Payments on Convertible Notes (Detail) Details 42 false false All Reports Book All Reports kpti-20220331.htm kpti-20220331.xsd kpti-20220331_cal.xml kpti-20220331_def.xml kpti-20220331_lab.xml kpti-20220331_pre.xml kpti-ex10_3.htm kpti-ex10_4.htm kpti-ex10_5.htm kpti-ex10_8.htm kpti-ex31_1.htm kpti-ex31_2.htm kpti-ex32_1.htm kpti-ex32_2.htm http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true